Ann Rheum Dis
http://www.ncbi.nlm.nih.gov/pubmed/34049859
80(11):1385-1392
https://connects.catalyst.harvard.edu/Profiles/profile/181650023
Investigating changes in disease activity as a mediator of cardiovascular risk reduction with methotrexate use in rheumatoid arthritis.
Ann Rheum Dis
http://www.ncbi.nlm.nih.gov/pubmed/34049859
80(11):1385-1392
https://connects.catalyst.harvard.edu/Profiles/profile/181650023